Somatotropin ( DrugBank: Somatotropin )

4 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
3	脊髄性筋萎縮症	1
65	原発性免疫不全症候群	1
78	下垂体前葉機能低下症	4
236	偽性副甲状腺機能低下症	1

3. 脊髄性筋萎縮症

臨床試験数 : 237 / 薬物数 : 123 - (DrugBank : 29) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 75

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00533221 (ClinicalTrials.gov)	October 2007	12/9/2007	Pilot Study of Growth Hormon to Treat SMA Typ II and III	Can Treatment With Human Growth Hormone Increase Strength in Spinal Muscular Atrophy Type II and III ...	Muscular Atrophy, Spinal	Drug: somatotropin;Drug: Placebo	University Hospital Freiburg	Novo Nordisk A/S	Completed	6 Years	35 Years	Both	20	Phase 2	Germany

First Previous1Next Last

65. 原発性免疫不全症候群

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2009-015739-34-DE (EUCTR)	09/12/2009	14/09/2009	Status of the growth hormone/ insulin-like growth factor-1 (GH/IGF-1) axis in relation to growth fai ...	Status of the growth hormone/ insulin-like growth factor-1 (GH/IGF-1) axis in relation to growth fai ...	This study will evaluate the status of the growth hormone/ insulin-like growth factor-1 (GH/IGF-1) a ...	Trade Name: Catapresan 75, Tabletten INN or Proposed INN: Clonidinhydrochlorid Trade Name: L-Arginin-h ...	Goethe-Universität Frankfurt/Main	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Germany

First Previous1Next Last

78. 下垂体前葉機能低下症

臨床試験数 : 492 / 薬物数 : 341 - (DrugBank : 47) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 100

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-001674-32-FI (EUCTR)	29/04/2009	25/08/2008	NordiNet International Outcome Study (NordiNet IOS) - NordiNet IOS	NordiNet International Outcome Study (NordiNet IOS) - NordiNet IOS	Small Gestation Age, Turner Syndrome, Growth Hormone Deficiency MedDRA version: 16.1;Level: PT;Class ...	Trade Name: Norditropin INN or Proposed INN: somatotropine	Novo Nordisk Farma Oy	NULL	Not Recruiting			Female: yes Male: yes	17000	Phase 4	Finland
2	NCT01576861 (ClinicalTrials.gov)	January 2007	19/3/2012	Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart Failure		Growth Hormone Deficiency;Chronic Heart Failure	Drug: Somatotropin	Federico II University	NULL	Completed	18 Years	80 Years	Both	28	Phase 2	Italy
3	NCT00591760 (ClinicalTrials.gov)	December 2004	20/12/2007	Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial	Correction of Growth Hormone Deficiency in Patients With Chronic Heart Failure: a Randomized, Contro ...	Heart Failure;Growth Hormone Deficiency;Ischemic Heart Disease	Drug: Somatotropin	Federico II University	NULL	Completed	18 Years	80 Years	All	56	Phase 2	NULL
4	NCT00497484 (ClinicalTrials.gov)	February 1995	5/7/2007	Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)	Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)	Pseudohypoparathyroidism;Growth Hormone Deficiency, Dwarfism	Drug: recombinant human somatotropin	University of Milan	Eli Lilly and Company	Active, not recruiting	1 Year	18 Years	Both		N/A	Italy

First Previous1Next Last

236. 偽性副甲状腺機能低下症

臨床試験数 : 3 / 薬物数 : 3 - (DrugBank : 2) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 23

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00497484 (ClinicalTrials.gov)	February 1995	5/7/2007	Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)	Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)	Pseudohypoparathyroidism;Growth Hormone Deficiency, Dwarfism	Drug: recombinant human somatotropin	University of Milan	Eli Lilly and Company	Active, not recruiting	1 Year	18 Years	Both		N/A	Italy

First Previous1Next Last

先頭へ